Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00049166Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat CancerTreatment